Cross-reactive type IV hypersensitivity reactions to benzodiazepines revealed by patch testing.
Kämpgen
E
E
Department of Dermatology, University of Würzburg, Germany.
Bürger
T
T
Bröcker
E B
EB
Klein
C E
CE
D014151:Anti-Anxiety Agents / Q000009:adverse effects*; D001569:Benzodiazepines; D001570:Benzodiazepinones / Q000009:adverse effects*; D003429:Cross Reactions; D017449:Dermatitis, Allergic Contact / Q000175:diagnosis*; D003975:Diazepam / Q000009:adverse effects; D005260:Female; D006801:Humans; D006968:Hypersensitivity, Delayed / Q000175:diagnosis*; D008875:Middle Aged; D010328:Patch Tests; D011537:Pruritus / Q000139:chemically induced
D014151:Anti-Anxiety Agents; D001570:Benzodiazepinones; D001569:Benzodiazepines; C005245:tetrazepam; D003975:Diazepam